A New Way to Fight Fungal Disease: Disarm the Pathogen Instead of Killing It
This article explains a promising anti-virulence approach to fungal disease and the practical decisions farmers should make while it is still being validated.
Display image: Lucas van Oort on Unsplash.
Why this research is different
Most fungicides work by stopping fungal growth, respiration, sterol production or another essential process. That can be effective, but strong selection pressure may favor resistant individuals. A study published October 13 tested a different idea: interfere with the fungal machinery that exports effectors—molecules pathogens use to manipulate plants and establish disease. The researchers focused on a cargo receptor called Erv29 in the rice-blast fungus and identified a small molecule, called 0442 in the paper, that interacted with the receptor pocket.
What the study showed
The compound reduced disease in controlled assays involving rice blast. The researchers also reported activity in detached or controlled plant tissues against Botrytis cinerea on tomato fruit, Colletotrichum fructicola on apple fruit and Rhizoctonia solani on rice leaves. Importantly, the molecule did not simply stop vegetative fungal growth on laboratory medium. That pattern supports an anti-virulence interpretation: the fungus may remain alive but become less able to deliver the tools it needs for successful infection.
Why it matters on the farm
A genuinely selective anti-virulence product could add a new mode of action to resistance-management programs. It could potentially preserve useful organisms better than a broad fungicide, depending on selectivity. It may also work across several fungal diseases if the target is sufficiently conserved. Those are possibilities, not established benefits. The current evidence comes from early controlled assays, not replicated commercial-field trials, and compound 0442 is not a registered product.
Six actions farmers can take now
1. Keep using integrated disease management. Start with resistant varieties, clean seed, crop rotation, canopy management and sanitation where applicable.
2. Rotate labeled fungicide modes of action. Do not rely repeatedly on one FRAC group, especially when disease pressure is high.
3. Apply preventively when the label and disease forecast support it. Many foliar fungicides protect better before infection becomes established.
4. Diagnose the pathogen. A product for Botrytis will not automatically solve bacterial spot, viral disease or an abiotic disorder.
5. Record treatment timing, weather and disease progress. These records reveal whether failure came from resistance, timing, coverage or an incorrect diagnosis.
6. Treat early anti-virulence claims as research signals. Ask for replicated greenhouse and field evidence, crop safety, residue information and comparison with commercial standards.
What must be proven next
Researchers need dose-response studies on whole plants, preventive and curative timings, persistence under sunlight and rain, crop selectivity, effects on beneficial fungi, environmental fate and repeated field trials. Resistance risk still exists: pathogens could modify the target or use alternative secretion routes. Developers should passage pathogens under sublethal exposure and monitor sensitivity. A commercially useful product must also be economical and stable in a formulation that reaches the infection site.
The practical conclusion
The Erv29 study opens an attractive discovery path: stop the pathogen from deploying virulence factors rather than relying only on growth inhibition. For farmers, the immediate lesson is not to buy an unproven molecule. It is to demand new modes of action while protecting the tools already available through diagnosis, rotation and sound IPM. Learn. Apply. Grow.
Primary research: https://doi.org/10.1186/s42483-026-00455-4 Practical learning: https://wise-farmer.com/wf-courses/
Discussion question: Which fungal disease on your farm most needs a genuinely new mode of action?
Discover more from Wise Farmer
Subscribe to get the latest posts sent to your email.